Biocon and Equillium expand exclusive licensing agreement for Itolizumab to include Australia and…
Equillium had originally secured exclusive rights to develop and commercialize Biocon’s novel biologic, itolizumab, for the US and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biocon
Biocon appoints Siddharth Mittal as its CEO and Joint MD
He takes over from Dr Arun Chandavarkar who retired as Chief Executive Officer & Joint Managing Director of Biocon on November…
USFDA approves Biocon’s sBLA for Pegfilgrastim new manufacturing facility
Expanded capacity will enable greater patient access globally
ICMR honours Kiran Mazumdar-Shaw with Lifetime Achievement Award
Shaw was recognised for her philanthropic efforts, and providing better healthcare to people in India and globally through…
Biocon features in the ASIA IP ELITE list for the fourth consecutive year
Biocon Biologics debuts on the ASIA IP ELITE 2019 list
Biocon moves up to rank no 6 on Science Careers’ top 20 global pharma and biotech employers list…
Ranked at number six among global pharma and biotech companies in 2019, Biocon has moved up from number seven in 2018 and number…
Biocon announces Q2FY20 Earnings
Net profit on a yoy basis was lower at Rs 216 crore (vs. Rs 355 corer in Q2FY19) due to an exceptional income of Rs 171 crore…
Biocon Biologics, Just – Evotec Biologics ink licensing pact for biosimilar asset
Through this in-licensing deal, Biocon Biologics has expanded its current therapeutic basket of biosimilars going beyond diabetes,…
Biocon, Mylan launch insulin biosimilar in Australia
Insulin glargine is indicated for the treatment of type 1 diabetes mellitus in adults, adolescents and children aged six years and…
Biocon subsidiary acquires research facility from Pfizer Healthcare
The facility is expected to be operational in a few months post qualification and will house over 250 scientists
Biocon said…